Blog - Page 24 of 5384 - QualityStocks

TuesdayMay 27, 2025 9:00 am

Cannabis Means Business – Conference & Expo to be Held as a B2B Conference in New York City

The Cannabis Means Business Conference & Expo will be held on June 4-5, 2025, in New York City as a two-day B2B event. Formerly known as CWBExpo, CMB has been operational since 2015. CMB highlights include: The pre-show workshops and rooftop party will be held on June 3, 2025. The Expo & Conference & O2VAPE Industry Yacht Party will be held on June 4 The Expo & Conference & Women in Cannabis Business Luncheon will be held on June 5 CMB caters to the innovative, business, and creative needs of the vibrant cannabis industry in New York City. It offers…

FridayMay 23, 2025 3:23 pm

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) Unveils New Exploration Target, Boosting Montauban Project Potential

ESGold (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, recently reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. “According to a company press release, internal analysis of historical VTEM (Versatile Time Domain Electromagnetic) survey data and drill records has highlighted this area as a high-priority exploration target,” reads a recent article. “The zone, which has not yet been tested by drilling, displays a strong combination of electromagnetic conductivity and magnetic response, a dual signal often associated…

FridayMay 23, 2025 2:23 pm

QualityStocksNewsBreaks – Why ONAR Holding Corp. (ONAR) Is ‘One to Watch’

ONAR (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. “Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide,” reads a recent article discussing the company. “Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings…

FridayMay 23, 2025 12:00 pm

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Featured in Noble Research Report, Earns ‘Outperform’ Rating and C$0.70 and US$0.50 Price Target

Noble Capital Markets Research released a comprehensive analysis of Nicola Mining. Nicola distinguishes itself among junior mining companies by combining exploration potential with operational cash flow, report states. Noble report also noted the company’s “superb corporate governance,” led by CEO Peter Espig, former 20-year Goldman Sachs banker. Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research (https://ibn.fm/3CDHY). The report gave the company an "Outperform" rating and a 12-month price target of C$0.70 and US$0.50 per share while highlighting Nicola Mining's diversified asset…

FridayMay 23, 2025 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics

The overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, posing a significant threat to public health. Soligenix’s SGX943 is a novel broad-spectrum therapy designed to treat bacterial infections without relying on conventional antibiotics. Preclinical studies have demonstrated the efficacy of SGX943 in various models of bacterial infection. In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum therapy designed to combat bacterial infections without relying…

FridayMay 23, 2025 10:30 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric clinics. The acquisition brings profitability and is expected to be accretive to both revenue and EBITDA. Kadima’s founder and medical director, Dr. David Feifel, a leader in interventional psychiatry, will join HOPE as Chief Medical Innovation Officer. NRx’s pipeline includes investigational drugs for suicidal bipolar depression and chronic pain. HOPE is targeting 30 clinic acquisitions by the end of 2025, projecting $100M in annual revenue. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical…

FridayMay 23, 2025 9:45 am

FAVO Capital Inc. (FAVO): Positioned to Capitalize on Small Business Lending Revival

FAVO Capital has filed to uplist to Nasdaq, aiming to scale its private credit model U.S. small business lending is drawing renewed policy attention amid fintech innovation FAVO strengthening strategic partnership with Stewards Investment Capital Limited through Series A equity Investment Recently announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower…

FridayMay 23, 2025 9:29 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Global Reach with Juve Stabia Serie A Playoff Match Streaming in U.S., Canada and UK

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B club S.S. Juve Stabia will stream its second Serie A playoff semifinal match against Cremonese live and free on Sunday, May 25, via Destination Calcio TV in the U.S., Canada and the UK. This follows Juve Stabia’s 2-1 win in the first leg. The international broadcast underscores Brera’s strategy to grow Juve Stabia’s global visibility through media access, fan engagement, and its multi-club ownership model. Executive Chairman Daniel McClory said the exposure builds the club’s audience in key markets and highlights its compelling underdog narrative following its upset of City…

FridayMay 23, 2025 9:10 am

QualityStocksNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports $58.2 Million Net Income for Fiscal 2025, Revenue Up 39 Percent

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported $58.2 million in net income for the fiscal year ended March 31, 2025, up 60% from the prior year, on revenue of $298.9 million, a 39% increase. Fiscal 2025 production included 7.5K oz of gold, 6.9M oz of silver, 62.2M lb of lead and 23.3M lb of zinc. The company also posted adjusted earnings of $75.1 million or $0.37 per share, with cash flow from operations reaching $138.6 million. In Q4, Silvercorp reported a net loss of $7.6 million due to a $20.6 million non-cash derivative charge, but adjusted quarterly net income came…

FridayMay 23, 2025 9:00 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows

Intelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug Screening System. The company’s FDA 510(k) submission included validation studies showing 94.1% accuracy in detecting opiates through fingerprint sweat. INBS is already active in 24 countries, with over 450 commercial accounts globally, and adoption growing across diverse industries, including logistics, mining, retail, and marine operations. The firm is expanding its distributor network to support localized growth ahead of its U.S. market entry. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S.…

Site Search

Company Search